Document is current
Any future updates will be listed below
-
Authors
Knoerl, Robert https://orcid.org/0000-0002-6996-5068
Mazzola, Emanuele
Pazyra-Murphy, Maria
Ryback, Birgitta
Frazier, A. Lindsay
Freeman, Roy L.
Hammer, Marilyn
LaCasce, Ann
Ligibel, Jennifer
Luskin, Marlise R.
Berry, Donna L.
Segal, Rosalind A.
-
Funding
Funding for this research was provided by:
National Institute of Nursing Research (K23NR018689)
National Cancer Institute (R01CA205255)
- License Information
-
More Information
Article History
Received: 2 April 2024
Accepted: 23 September 2024
First Online: 28 September 2024
Declarations
:
: Study oversight and institutional review board approval was provided by the Dana-Farber/Harvard Cancer Center Office for Human Research Studies (19–862). Verbal informed consent was obtained from all study participants. A waiver of documentation of informed consent was approved by the institutional review board due to the minimal risk nature of the study and the need for social distancing due to the COVID-19 pandemic.
: Not applicable.
: RK has received personal fees (consulting) from the Comprehensive and Integrative Medicine Institute. ML has received research funding from Novartis and Abbive and serves on advisory boards for Pfizer, Novartis, and Jazz. No other authors have any disclosures to report.
